Unknown

Dataset Information

0

Combination GLP-1 and Insulin Treatment Fails to Alter Myocardial Fuel Selection vs. Insulin Alone in Type 2 Diabetes.


ABSTRACT:

Context

It is unclear if effects of glucagon-like peptide-1 (GLP-1) and clinically available GLP-1 agonists on the heart occur at clinical doses in humans, possibly contributing to reduced cardiovascular disease risk.

Objective

To determine whether liraglutide, at clinical dosing, augments myocardial glucose uptake (MGU) alone or combined with insulin compared with insulin alone in metformin-treated type 2 diabetes mellitus (T2D).

Design

In a randomized clinical trial of patients with T2D treated with metformin plus oral agents or basal insulin, myocardial fuel use was compared after 3 months of treatment with insulin detemir, liraglutide, or combination detemir plus liraglutide added to background metformin.

Main outcome measures

Myocardial blood flow (MBF), fuel selection, and rates of fuel use were evaluated using positron emission tomography, powered to demonstrate large effects.

Results

MBF was greater in the insulin-treated groups [median (25th, 75th percentile): detemir, 0.64 mL/g/min (0.50, 0.69); liraglutide, 0.52 mL/g/min (0.46, 0.58); detemir plus liraglutide, 0.75 mL/g/min (0.55, 0.77); P = 0.035 comparing three groups, P = 0.01 comparing detemir groups to liraglutide alone]. There were no evident differences among groups in MGU [detemir, 0.040 µmol/g/min (0.013, 0.049); liraglutide, 0.055 µmol/g/min (0.019, 0.105); detemir plus liraglutide, 0.037 µmol/g/min (0.009, 0.046); P = 0.68 comparing three groups]. There were no treatment-group differences in measures of myocardial fatty acid uptake or handling, and no differences in total oxidation rate.

Conclusion

These observations argue against large effects of GLP-1 agonists on myocardial fuel metabolism as mediators of beneficial treatment effects on myocardial function and ischemia protection.

SUBMITTER: Mather KJ 

PROVIDER: S-EPMC6126889 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Combination GLP-1 and Insulin Treatment Fails to Alter Myocardial Fuel Selection vs. Insulin Alone in Type 2 Diabetes.

Mather Kieren J KJ   Considine Robert V RV   Hamilton LaTonya L   Patel Niral A NA   Mathias Carla C   Territo Wendy W   Goodwill Adam G AG   Tune Johnathan D JD   Green Mark A MA   Hutchins Gary D GD  

The Journal of clinical endocrinology and metabolism 20180901 9


<h4>Context</h4>It is unclear if effects of glucagon-like peptide-1 (GLP-1) and clinically available GLP-1 agonists on the heart occur at clinical doses in humans, possibly contributing to reduced cardiovascular disease risk.<h4>Objective</h4>To determine whether liraglutide, at clinical dosing, augments myocardial glucose uptake (MGU) alone or combined with insulin compared with insulin alone in metformin-treated type 2 diabetes mellitus (T2D).<h4>Design</h4>In a randomized clinical trial of pa  ...[more]

Similar Datasets

| S-EPMC1158101 | biostudies-other
| S-EPMC3213132 | biostudies-literature
| S-ECPF-GEOD-37131 | biostudies-other
| S-EPMC3662998 | biostudies-literature
| S-EPMC8671299 | biostudies-literature
| S-EPMC8583813 | biostudies-literature
2023-06-29 | PXD043032 | Pride
2025-03-28 | GSE262677 | GEO
| S-EPMC7192721 | biostudies-literature
| S-EPMC10361819 | biostudies-literature